CAPRELSA cpr pell 300 mg 30 pce
7680623410023
CH-62341
L01EX04
07.16.1.
Reimbursement limitations:
CAPRELSA3
Pour le traitement des patients atteints du cancer médullaire de la thyroïde (CMT) agressif et …
1 / 3
google
Details
- Product number
- 6234102
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- vandetanibum 300 mg, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, crospovidonum, povidonum K 29-32, magnesii stearas, pellicule: hypromellosum, macrogolum 300, E 171, pro compresso obducto.
Articles (1)
Caprelsa 300 mg, comprimés pelliculés
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 4907.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2012
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 62341
- Drug name
- Caprelsa, comprimés pelliculés
- Galenic form
- TAB
- ATC Code
- L01EX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 01/05/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CAPRELSA cpr pell 300 mg 30 pce
- Description (DE)
- CAPRELSA Filmtabl 300 mg 30 Stk
- Market launch
- 01/05/2012
- Narcotic (BTM)
- No